共 65 条
[1]
Brauner A., Fridman O., Gefen O., Balaban N.Q., Distinguishing between resistance, tolerance and persistence to antibiotic treatment, Nat Rev Microbiol, 14, pp. 320-330, (2016)
[2]
Brown E.D., Wright G.D., Antibacterial drug discovery in the resistance era, Nature, 529, pp. 336-343, (2016)
[3]
Bhardwaj P., Hans A., Ruikar K., Guan Z., Palmer K.L., Reduced chlorhexidine and daptomycin susceptibility in vancomycin-resistant Enterococcus faecium after serial chlorhexidine exposure, Antimicrob Agents Chemother, 62, (2018)
[4]
Cieplik F., Jakubovics N.S., Buchalla W., Maisch T., Hellwig E., Al-Ahmad A., Resistance toward chlorhexidine in oral Bacteria—is there cause for concern?, Front Microbiol, 10, (2019)
[5]
Fabbri S., Johnston D.A., Rmaile A., Gottenbos B., De Jager M., Aspiras M., Et al., High-velocity microsprays enhance antimicrobial activity in Streptococcus mutans biofilms, J Dent Res, 95, pp. 1494-1500, (2016)
[6]
Filho J.G., Vizoto N.L., Luiza De Aguiar Loesch M., Dias De Sena M., Mendes Da Camara D., Caiaffa K.S., Et al., Genetic and physiological effects of subinhibitory concentrations of oral antimicrobial agents on Streptococcus mutans biofilms, Microb Pathog, 150, (2021)
[7]
Koo H., Allan R.N., Howlin R.P., Stoodley P., Hall-Stoodley L., Targeting microbial biofilms: current and prospective therapeutic strategies, Nat Rev Microbiol, 15, pp. 740-755, (2017)
[8]
Bowen W.H., Burne R.A., Wu H., Koo H., Oral biofilms: pathogens, matrix, and polymicrobial interactions in microenvironments, Trends Microbiol, 26, pp. 229-242, (2018)
[9]
Dewhirst F.E., Chen T., Izard J., Paster B.J., Tanner A.C.R., Yu W.-H., Et al., The human oral microbiome, J Bacteriol, 192, pp. 5002-5017, (2010)
[10]
Costerton J.W., Stewart P.S., Greenberg E.P., Bacterial biofilms: a common cause of persistent infections, Science, 284, pp. 1318-1322, (1999)